METZGER MICHAEL A (President and COO) sold 1.4% of their position (7.41K shares) of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $152.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/6/2026ACC: 0001193125-26-041500
Officer· President and COO
Since Feb 2019
+650.19K
Net shares
Net buyer
$152.8K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
657.60K acquired · 7.41K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+73K
Price / share
—
Trade value
—
% of position
24.4%
2/4/2026
298.66K→371.66K
Common Stock
Direct
Shares
+144.60K
Price / share
—
Trade value
—
% of position
38.9%
2/4/2026
371.66K→516.26K
Common Stock
Direct
Shares
−7.41K
Price / share
$20.62
Trade value
$152.84K
% of position
1.4%
2/6/2026
516.26K→508.85K
Total
Net shares
+210.19K
Net value
-$152.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2026 | A · Award | +73K | — | — | 24.4% | 298.66K | 371.66K |
| Common Stock Direct | 2/4/2026 | A · Award | +144.60K | — | — | 38.9% | 371.66K | 516.26K |
| Common Stock Direct | 2/6/2026 | S · Sale | −7.41K | $20.62 | $152.84K | 1.4% | 516.26K | 508.85K |
| Total | +210.19K | -$152.84K | ||||||
Derivative Transactions1
Stock Options (Right to buy)
Direct
Converts to
Common Stock
440K shares
Shares
+440K
Strike price
20.43
Held after
440K
Exercisable
—
2/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) Direct | Common Stock440K shares | 2/4/2026 | A · Award | +440K | 20.43 | — | 440K |